Abstract / Summary
Study Objectives: To characterize neural correlates of memory and emotion reactivity in individuals with insomnia disorder (INS) compared to good sleepers (GS) and to investigate associated short- and long-term changes following cognitive-behavioural therapy for insomnia (CBTi). Methods: This randomized controlled trial included 56 INS and 20 GS. At baseline, participants underwent resting-state and task-based functional magnetic resonance imaging, including working memory, emotion reactivity, and face-name associative memory tasks. They filled out sleep diaries and self-report questionnaires about sleep, cognition, and emotions, and underwent in-lab polysomnography. Subsequently, participants with INS were randomized to either the 3-month treatment group (TX) or wait-list control group (WL). Both TX and WL groups repeated baseline assessments at three months post-randomization and completed sleep diaries and questionnaires one year after finishing CBTi. Results: At baseline, the INS group reported higher insomnia severity, greater subjective cognitive impairment, and perceived sleep-related stimuli as more negative than GS. Contrasting with these subjective evaluations, no group differences were found in memory performance, task-based brain activity, or resting-state functional connectivity. At three months post-randomization and one-year follow-up, CBTi significantly improved subjective, but not objective, cognitive functioning and sleep in adults with INS. No significant treatment-related changes were observed in valence ratings of sleep images, task-based brain activity, or resting-state functional connectivity. Conclusions: Beyond its primary role in improving insomnia symptoms, CBTi may have long-term benefits for individuals with INS who experience concerns about their cognitive functioning, even in the absence of objective changes in neural processing of cognitive and emotional tasks.